Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting.
第一作者:
Xueshuai,Wan
第一单位:
Department of Liver Surgery, Peking Union Medical College Hospital, PUMC, and Chinese Academy of Medical Sciences, Beijing, P. R. China.
作者:
医学主题词
人类(Humans);癌, 肝细胞(Carcinoma, Hepatocellular);乙型肝炎表面抗原(Hepatitis B Surface Antigens);肝肿瘤(Liver Neoplasms);乙型肝炎病毒(Hepatitis B virus);肝细胞(Hepatocytes);T淋巴细胞(T-Lymphocytes);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);男(雄)性(Male);中年人(Middle Aged);动物(Animals);HLA-A2抗原(HLA-A2 Antigen)
DOI
10.3350/cmh.2024.0058
PMID
38808361
发布时间
2025-02-05
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



